You are here

Article Text

Article menu
Download PDFPDF
Education in Heart
Acute cardiovascular care
Myocardial revascularisation in high-risk subjects
  1. Satpal S Arri,
  2. Tiffany Patterson,
  3. Rupert P Williams,
  4. Konstantinos Moschonas,
  5. Christopher P Young,
  6. Simon R Redwood
  1. Cardiovascular Department, Guy’s and St Thomas' NHS Foundation Trust, London, UK
  1. Correspondence to Dr Satpal S Arri, Cardiovascular Department Guy’s and St Thomas' NHS Foundation Trust London UK, SE1 7EH, UK; satpal.arri{at}gstt.nhs.uk

https://doi.org/10.1136/heartjnl-2016-310487

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Learning objectives

    • Risk assessment in myocardial revascularisation

    • Complications of percutaneous and surgical revascularisation

    • The role of haemodynamic support

    Introduction

    The synergistic effect of comorbidity, coronary artery lesion complexity and left ventricular (LV) systolic function can significantly increase the risk of adverse events at the time of myocardial revascularisation (figure 1). In patients with LV dysfunction and a large territory of ischaemia who have little reserve, further reductions in blood pressure can result in a spiral of haemodynamic compromise, culminating in cardiogenic shock or even death. In this article, we address factors that confer increased risk, current tools to quantify and guide revascularisation strategy in such patients; concluding with interventions to minimise risk including haemodynamic support devices, involvement of the heart team and technical considerations during procedural planning.

    Figure 1

    Factors increasing the risk of myocardial revascularisation. LMS, left main stem; LV, left ventricle.

    Comorbidity

    An increasing number of revascularisation procedures are performed in patients over 70, despite poor representation in randomised controlled trials (RCT).1–3 Elderly patients are more likely to present with extensive coronary artery disease (CAD), higher lesion complexity and multiple comorbidities. Increasing age is associated with up to fourfold increased risk of death, myocardial infarction (MI), stroke, renal failure and bleeding, following percutaneous coronary intervention (PCI), in both the acute and elective setting.4 5 Older age is also a predictor of in-hospital mortality and stroke following coronary artery bypass grafting (CABG) surgery, with the worst outcomes in those following urgent and emergency surgery.3 6 7

    There is often disparity between chronological and biological age, which is more difficult to quantify. ‘Frailty’, a syndrome of physical functional decline, malnourishment, cognitive impairment and reduced physical capacity to stressors, is itself associated with adverse outcomes.8 9 The Charlson comorbidity index attempts to address some of these additional factors and has been shown to predict 1-year mortality in cardiac …

    View Full Text

    Footnotes

    • Contributors All authors (SSA, TP, RPW, KM, CPY, SRR) were responsible for drafting and revising the manuscript. SSA is responsible for the overall content as guarantor.

    • Competing interests None declared.

    • Provenance and peer review Commissioned; externally peer reviewed.